TECTONIC THERAPEUTIC, INC. Public Float
TECTONIC THERAPEUTIC, INC. (TECX) had Public Float of $232.00 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $232.00M.
- 2024-06-30: Entity Public Float $115.00M.
- 2023-06-30: Entity Public Float $36.57M.
- 2022-06-30: Entity Public Float $34.84B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $232.00M 10-K · filed 2026-02-26 |
| 2024-06-30 | $115.00M 10-K · filed 2025-03-20 |
| 2023-06-30 | $36.57M 10-K · filed 2024-03-14 |
| 2022-06-30 | $34.84B 10-K · filed 2023-03-23 |
| 2021-06-30 | $336.93M 10-K · filed 2022-03-17 |
| 2020-06-30 | $533.95M 10-K · filed 2021-03-18 |
| 2019-06-28 | $289.23M 10-K · filed 2020-03-16 |
| 2018-06-29 | $360.59M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |